Authorities report 37 new COVID-19 cases in Saudi Arabia
The Saudi Ministry of Health recorded 37 new confirmed COVID-19 cases and 44 recoveries in the Kingdom on Tuesday, with the number of critical cases reaching 50.
The statistics showed that the total number of infections in the country reached 549,297 while the recovery tally reached 538,373.
Two new deaths were recorded, bringing the tally of fatalities in the Kingdom to 8,818.
The authorities advised everyone with queries to contact the toll free number (937) for consultations and inquiries around the clock, and to obtain health information and services.
Separately, Pfizer Inc. said on Tuesday it will allow generic manufacturers to supply its experimental antiviral COVID-19 pill to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool.
The voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licences to qualified generic drug manufacturers to make their own versions of PF-07321332. Pfizer will sell the pills it manufactures under the brand name Paxlovid.
From the rest of the world, the Nikkei daily reported on Tuesday that Japan intends to ease quarantine rules by the end of November for people inoculated with Johnson & Johnson’s COVID-19 vaccine.
Last week the country took a first step in its planned phased re-opening of borders, which centers on business travelers.
Two new deaths were recorded, bringing the tally of fatalities in the Kingdom to 8,818.
The authorities advised everyone with queries to contact the toll free number (937) for consultations and inquiries around the clock, and to obtain health information and services.
Separately, Pfizer Inc. said on Tuesday it will allow generic manufacturers to supply its experimental antiviral COVID-19 pill to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool.
The voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licences to qualified generic drug manufacturers to make their own versions of PF-07321332. Pfizer will sell the pills it manufactures under the brand name Paxlovid.
From the rest of the world, the Nikkei daily reported on Tuesday that Japan intends to ease quarantine rules by the end of November for people inoculated with Johnson & Johnson’s COVID-19 vaccine.
Last week the country took a first step in its planned phased re-opening of borders, which centers on business travelers.
